The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-12

AUTHORS

Angus G. Dalgleish, Peter C. L. Beverley, Paul R. Clapham, Dorothy H. Crawford, Melvyn F. Greaves, Robin A. Weiss

ABSTRACT

Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by ‘opportunistic neoplasms’ (for example, Kaposi's sarcoma)1. Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen2 (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients3–5 is strongly implicated in the aetiology of AIDS because of the high frequency of isolation4 and the prevalence of specific antibodies6–8 in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS. More... »

PAGES

763-767

References to SciGraph publications

Journal

TITLE

Nature

ISSUE

5996

VOLUME

312

Related Patents

  • Cvn-12p1: A Recombinant Allosteric Lectin Antagonist Of Hiv-1 Envelope Gp120 Interactions
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Combined Therapy For Treatment Of Hiv Infection
  • Contacting With Monoclonal Antibody Which Binds To Chemokine Receptor; Blocks Fusion And Inhibits Activation Of Inflammatory Response; Inhibiting Fusion Of Hiv-1 To Cd4+ Cells
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Recombinantly Preparing Antibody Fusion For Targeting And/Or Treating Metabolic Disorders
  • Pharmaceutical Being Used For Treating Hiv Infection, The Composition And Uses Thereof
  • Isolated Peptides Derived From Human Immunodeficiency Virus Types 1 And 2 Containing Fusion Inhibitory Domains
  • Drug Delivery Devices And Pharmaceutical Composition For Treatment Wasting Syndromes
  • Preventing The Viral Entry Process Into Target Cells, By Inhibiting The Binding Of Viral Surface Glycoprotein To Cell Surface Cd4, To Fusion Coreceptors Ccr5 Chemokine Receptors And The Transient Conformation Fusion Intermediate That Ultimately Folds Into A Conformation Capable Of Mediating Fusion
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Methods For The Inhibition Of Epstein-Barr Virus Transmission Employing Anti-Viral Peptides Capable Of Abrogating Viral Fusion And Transmission
  • Inhibition Of Hiv-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein
  • Clotting Factor-Fc Chimeric Proteins To Treat Hemophilia
  • Anti-Cd4 Antibody Homologs Useful In Prophylaxis And Treatment Of Aids, Arc And Hiv Infection
  • Method Of Raising Neutralizing Antibodies Against Hiv
  • Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Method For The Production Of Antibodies That Bind To Multiple Membrane Spanning Proteins
  • Nucleic Acids Encoding Self-Assembled, Non-Infectious, Non-Replicating, Immunogenic Retrovirus-Like Particles Comprising Modified Hiv Genomes And Chimeric Envelope Glycoproteins
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1)
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Microfluidic Particle-Analysis Systems
  • Anti-Ccr5 Antibody
  • Methods For Assaying Inhibition Of Hiv-1 Envelope Glycoprotein-Mediated Membrane Fusion
  • Population Of T4-Lymphocytes Specific For The Lav-Virus, Method For Their Production And Their Use In The Production Of This Virus
  • Multifunctional Self-Assembling Polymeric Nanosystems
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1)
  • Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Influenza Virus Transmission
  • Methods For Inhibition Of Membrane Fusion-Associated Events, Including Respiratory Syncytial Virus Transmission
  • Producing Antibody By Immunizing Rodents Or Monkeys With Cd4-Expressing T Cells (Either Normal Or From Lymphoma- Or Leukemia-Derived Cell Lines), Forming Hybridomas; Antibody Blocks Binding Of Gp120 To Cd4 Cells, Neutralizing Virus
  • Hiv Immunogenic Complexes
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Inhibiting Binding Of A Hiv Antigen To Receptors On Cells Of Mammals
  • Anti-Ccr5 Antibody
  • Peptide Vaccines And Associated Methods For Protection Against Feline Leukemia Virus
  • Genetic Engineering; Desroying Infections; Antitumor, Anticancer Agents
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Aids Virus Envelope Glycoprotein-Related Antigens, In Particular Precursors Of Such Glycoprotein, Processes For Obtaining Such Antigens, And Means Used In Such Processes, Applications Of Such Antigens To The Preparation Of Immunogen Compositions Aids Or Related Conditions
  • Small Peptides Which Inhibit Binding To T-4 Receptors And Act As Immunogens
  • Isolated Cytotoxic T-Cell Which Expresses A Membrane-Bound Chimeric Receptor Which Binds Target Cell And Signals To Destroy Bound Target Cell; Targets Infected, Cancerous, Tumor Or Autoimmune-Generated Cells
  • Methods For Inhibition Of Membrane Fusion-Associated Events, Including Hiv Transmission
  • Methods For Treating An Immune Disorder-Related Disease By Reducing Autoreactivity In A T Cell Compartment
  • Polypeptide; Genetic Engineering
  • Antibodies Which Recognize Cd4 Epitopes That Are Present Only After Interaction With Human Immmunodeficiency Virus Gp120; For Disruption Of Virus Attachment And Entry Without Interfering With Normal Cd4 Function; Vaccines; Immunotherapy
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Identifying Preferential Immunoglobulins For Use In Treatment And Prevention Of Infections And Cell Proliferative Disorders Via Repeated Screening Of Phage Library
  • Method Of Purifying Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Methods For Inhibition Of Membrane-Fusion-Associated Events, Including Hepatitis B Virus Transmission
  • Human Immunodeficiency Virus Type 1 (Hiv-1)-Neutralizing Human Single-Chain Antibodies With Improved Breadth And Potency
  • Derivatives Of Soluble T-4
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Compounds And Methods Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Preventing Fusion Of Virus And Preferential Cells; Incubate Cells With Genetically Engineered Viral Particles And Viricide, Detect Reduction In Emission Energy, Reduction In Emission Indicates Prevention Of Viral Fusion And Infection
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Simian Immunodeficiency Virus Peptides With Antifusogenic And Antiviral Activities
  • Methods For The Identification Of Compounds Capable Of Inhibiting Hiv-1 Viral Replication Employing Murine Cell Lines Expressing Human Topoisomerase I
  • Compositions And Methods For Inhibition Of Hiv-1 Infection
  • Antibodies And Antibody Fragments That Specifically Bind A Cd4-Inducible Hiv Gp120 Epitope That Is Enhanced By Binding A Co-Receptor For Hiv, Such As Chemokine Receptors, Used For Inhibiting Hiv Entry Into Cells And Inhibiting Replication Of Hiv In Mammals
  • The Retrovirus Siv Cpz-Ant And Its Uses
  • Polynucleotide Coding Binding Polypeptide; For Use In Prevention And Treatment Of Viral Diseases And Development Of Viricides
  • Treating A Subject Afflicted With Hiv-1 By Administering Anti-Viral Agent Selected From A Nonnucleoside Reverse Transcriptase Inhibitor, A Nucleoside Reverse Transcriptase Inhibitor, A Hiv-1 Protease Inhibitor, And A Hiv-1 Fusion Or Viral Entry Inhibitor
  • Polypeptide For The Use In The Prevention On Viral Infection; Viricides
  • Compounds And Methods Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Cytokines For Use In The Prevention Of Viral Infection; Obtain Cytokine, Incubate With Viral Infected And Wild Type Cells, Detect Viral Proteins, Monitor Ability To Produce Viral Protein In Presence Of Cytokine
  • Contacting With Monoclonal Antibody Which Binds To Chemokine Receptor; Blocks Fusion And Inhibits Activation Of Inflammatory Response
  • Synthetic Peptide Inhibitors Of Hiv Transmission
  • Population Of Lav Virus Specific T4 Lymphocytes, Their Process For Obtaining It And Their Application To The Production Of This Virus.
  • Theramutein Modulators
  • Suppressor Of Hiv Replication And Transcription
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Human Immunodeficiency Virus-Neutralizing Human Antibodies With Improved Breadth And Potency
  • Non-Human Antigen Binding Region And A Human Constant Region; Particularly Hiv-Neutralizing, Immunoglobulins
  • Methods And Compositions For Treatment Of Hiv-1 Infection Using Antiviral Compounds In Simultaneous Or Sequential Combinations
  • Monoclonal Antibodies And Fv Specific For Cd2 Antigen
  • Monoclonal Antibody Against The Ccr5 Chemokine Receptor
  • Antibody To Herpes Virus Entry Receptor Protein
  • Theramutein Modulators
  • A Method Of Detecting Infectious Aids Virus
  • Monoclonal Antibodies Which Neutralize Hiv-1 Infection
  • Fusion Proteins Comprising Dp-178 And Other Viral Fusion Inhibitor Peptides Useful For Treating Aids
  • Peptides From Transmembrane Protein, Gp41, From Human Immunodeficiency Virus; Viricides; Drug Screening; Intracellular Modulators Of Coiled-Coil Peptide Structures
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Clotting Factor-Fc Chimeric Proteins To Treat Hemophilia
  • Use In Identifying Genetic Suppressor Elements (Gses), Cellular Genes Corresponding To Such Gses, And Methods Of Using Such Cellular Genes And Their Encoded Products In Screening Assays For Selecting Additional Inhibitors Of Hiv
  • Polymorphs Of 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid Di-N-Methyl-D-Glucamine
  • Vaccines Containing Antibodies And Epitopes
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1) And Detection Of Antibodies Against Epitope (Gcsgklic)
  • Theramutein Modulators
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events Including Rsv Transmission
  • Population Of T4 Lymphocytes Specific Of Lav Virus, Process For Obtaining Them And Their Application To The Production Of Said Virus
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Method Of Purifying Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Has Affinity For And Binding Capability To Red Blood Cells; Nh2-Cd4-Gbp130-Cooh; Aids And Hiv
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Hiv Transmission
  • Chemokine Inhibition Of Immunodeficiency Virus
  • Selecting And Isolating Peripheral Blood Mononuclear Cells Infected With Human Immunodeficiency Virus, Then Contacting With Specific Antibody Or Ligand Which Prevents Production Of Virus In T Cells; Viricides
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Anti-Hiv-1 Monoclonal Antibodies Which Bind To A Viral Epitope, Thereby Neutralizing The Virus; Antigenic/Immunogenic Linear Peptide Of Hiv-1
  • Use In Identifying Genetic Suppressor Elements (Gses), Cellular Genes Corresponding To Such Gses, And Methods Of Using Such Cellular Genes And Their Encoded Products In Screening Assays For Selecting Additional Inhibitors Of Hiv
  • Theramutein Modulators
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events Including Rsv Transmission
  • Immunogenic Compositions Derived From Structural Alteration Of Hiv Envelope Proteins
  • Monoclonal Antibodies Which Neutralize Hiv-1 Infection
  • Polymorphs Of 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid Di-N-Methyl-D-Glucamine
  • Vaccines Containing Antibodies And Epitopes
  • Detecting Modulator Of Gene Transcription; Obtain Cell, Incubate With Defective Virus, Expose To Modulator, Monitor Adjustment In Gene Expression
  • The Retrovirus Siv Cpz-Ant And Its Uses
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Blocking Or Activation Of Endogenous Proteins Variations Rncoded By Mutated Gees
  • Treatment And Sustained Virologic Remission Of Hiv Infection By Antibodies To Cd4 In Haart Stabilized Patients
  • Antibodies Directed Against Cd4 For The Treatment And Functional Cure Of Hiv
  • Stabilized Single Human Cd4 Domains And Fusion Proteins
  • Vectors Expressing Hybrid Viruses, Methods Of Use And Novel Assays
  • Theramutein Modulators
  • Anti-Ccr5 Antibody
  • Acylated Betulin And Dihydrobetulin Derivatives, Preparation Thereof And Use Thereof
  • Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Use Of Peptides For Inhibition Of Human And Non-Human Retroviral, Especially Hiv, Transmission To Uninfected Cells
  • Inhibitory Of Human And Non-Human Retroviral, Especially Hiv, Transmission To Uninfected Cells.
  • Immunoassay Diagnostic Kit Containing Antigens Derived From Self-Assembled, Non-Infectious, Non-Replicating, Immunogenic Retrovirus-Like Particles Comprising Modified Hiv Genomes And Chimeric Envelope Glycoproteins
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Small Peptides Which Inhibit Binding To T-4 Receptors
  • Antigens Related To The Envelope Glycoprotein Of The Acquired Immunodeficiency Syndrome Virus
  • Exhibit Anti-Membrane Fusion Capability, Antiviral Activity, Such As The Ability To Inhibit Hiv Transmission To Uninfected Cells
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Assay For Detection Of Viral Fusion Inhibitors
  • As Inhibitory Of Human And Non-Human Retroviral, Especially Human Immunodeficiency Viurs (Hiv), Transmission To Uninfected Cells
  • Treatment Of Hiv And Other Viral Infections Using Combinatorial Therapy
  • Substituted 3′,4′-Di-O-Camphanoyl-(+)-Cis-Khellactone Analogs, Compositions Thereof, And Methods For Using Thereof
  • Methods For Inhibiting Hiv-1 Replication Involving The Administration Of An Anti-Ccr5 Receptor Monoclonal Antibody And Small Molecule Ccr5 Receptor Antagonist
  • Detecting Cd8+ By Contacting With Culture Of Cells That Contain Recombinant Dna Expression Vector In Which A Reporter Gene Is Associated With Promoter Sequence; Measuring Inhibition Of Reporter Gene; Can Use In Drugs For Aids
  • Comprise A Macromolecular Carrier Group Fused To A Gp41-Derived Dp178 Peptide Corresponding To Amino Acids 638 To 673 Of The Hiv-1la1 Gp41 Protein; Inhibitory Of Human And Non-Human Retroviral, Especially Hiv, Transmission To Uninfected Cells
  • Method Of Inducing An Immune Response Against Human Immunodeficiency Virus Comprising Administering Immunogenic Compositions Comprising Authentic Trimeric Hiv-1 Envelope Glycoproteins Containing A Long Linker And Tag
  • Hiv Immunogenic Complexes Comprising Gp120 Covalently Bound To Cd4 Or Concanavalin A
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/312763a0

    DOI

    http://dx.doi.org/10.1038/312763a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1021684259

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/6096719


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Acquired Immunodeficiency Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Surface", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deltaretrovirus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Virus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "T-Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vesicular stomatitis Indiana virus", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dalgleish", 
            "givenName": "Angus G.", 
            "id": "sg:person.01040665311.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040665311.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.439749.4", 
              "name": [
                "ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Beverley", 
            "givenName": "Peter C. L.", 
            "id": "sg:person.01060575403.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575403.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Clapham", 
            "givenName": "Paul R.", 
            "id": "sg:person.0636250107.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636250107.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.439749.4", 
              "name": [
                "ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Crawford", 
            "givenName": "Dorothy H.", 
            "id": "sg:person.0754431446.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754431446.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Greaves", 
            "givenName": "Melvyn F.", 
            "id": "sg:person.013377471142.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013377471142.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Weiss", 
            "givenName": "Robin A.", 
            "id": "sg:person.011763114607.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011763114607.07"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/312767a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028751316", 
              "https://doi.org/10.1038/312767a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1984-12", 
        "datePublishedReg": "1984-12-01", 
        "description": "Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by \u2018opportunistic neoplasms\u2019 (for example, Kaposi's sarcoma)1. Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen2 (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients3\u20135 is strongly implicated in the aetiology of AIDS because of the high frequency of isolation4 and the prevalence of specific antibodies6\u20138 in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/312763a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5996", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "312"
          }
        ], 
        "keywords": [
          "anti-CD4 antibodies", 
          "CD4 antigen", 
          "HTLV-II", 
          "AIDS retrovirus", 
          "retroviral envelope antigen", 
          "immune deficiency syndrome", 
          "receptor-bearing cells", 
          "T cell cultures", 
          "etiology of AIDS", 
          "virus-producing cells", 
          "opportunistic neoplasms", 
          "formation of syncytia", 
          "opportunistic infections", 
          "HTLV-III", 
          "deficiency syndrome", 
          "cell surface expression", 
          "envelope antigen", 
          "LAV-1", 
          "surface CD4", 
          "PGL patients", 
          "CD4", 
          "vesicular stomatitis virus", 
          "male homosexuals", 
          "monoclonal antibodies", 
          "productive infection", 
          "cell surface receptors", 
          "susceptibility of cells", 
          "antigen", 
          "AIDS", 
          "infection", 
          "receptors", 
          "causative agent", 
          "antibodies", 
          "patients", 
          "stomatitis virus", 
          "HTLV", 
          "pseudotypes", 
          "cells", 
          "retroviruses", 
          "syncytia", 
          "lymphadenopathy", 
          "neoplasms", 
          "high frequency", 
          "syndrome", 
          "Kaposi", 
          "etiology", 
          "prevalence", 
          "specific components", 
          "virus", 
          "essential component", 
          "expression", 
          "agents", 
          "susceptibility", 
          "subset", 
          "homosexuals", 
          "contrast", 
          "culture", 
          "frequency", 
          "components", 
          "formation", 
          "example"
        ], 
        "name": "The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus", 
        "pagination": "763-767", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1021684259"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/312763a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "6096719"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/312763a0", 
          "https://app.dimensions.ai/details/publication/pub.1021684259"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_176.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/312763a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/312763a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    196 TRIPLES      21 PREDICATES      96 URIs      87 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/312763a0 schema:about N44f248c6d5494f88882165d78a3da128
    2 N4850ca447dec43af91c81d7cf87072e4
    3 N8449f7608c694c5cb7ce3f697e6efb91
    4 N881ceeb37c86451cbfb61540a9580a35
    5 N8fec1c6395494597b8f58d6f4bf412e7
    6 N9382a04d78be4ef986ccdcd644da45ae
    7 Ne04dfa8663e842c39c8dd523671861bf
    8 Nf811a0cdcdbc40518c969b4a14baceec
    9 anzsrc-for:11
    10 anzsrc-for:1107
    11 schema:author N2a985761354d4464a03c450a13c5d0f0
    12 schema:citation sg:pub.10.1038/312767a0
    13 schema:datePublished 1984-12
    14 schema:datePublishedReg 1984-12-01
    15 schema:description Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by ‘opportunistic neoplasms’ (for example, Kaposi's sarcoma)1. Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen2 (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients3–5 is strongly implicated in the aetiology of AIDS because of the high frequency of isolation4 and the prevalence of specific antibodies6–8 in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS.
    16 schema:genre article
    17 schema:isAccessibleForFree false
    18 schema:isPartOf N9e452347fbe54d9489c5d039140779bc
    19 Nf19e74a8074f4bc7b22ea6f4e49519e7
    20 sg:journal.1018957
    21 schema:keywords AIDS
    22 AIDS retrovirus
    23 CD4
    24 CD4 antigen
    25 HTLV
    26 HTLV-II
    27 HTLV-III
    28 Kaposi
    29 LAV-1
    30 PGL patients
    31 T cell cultures
    32 agents
    33 anti-CD4 antibodies
    34 antibodies
    35 antigen
    36 causative agent
    37 cell surface expression
    38 cell surface receptors
    39 cells
    40 components
    41 contrast
    42 culture
    43 deficiency syndrome
    44 envelope antigen
    45 essential component
    46 etiology
    47 etiology of AIDS
    48 example
    49 expression
    50 formation
    51 formation of syncytia
    52 frequency
    53 high frequency
    54 homosexuals
    55 immune deficiency syndrome
    56 infection
    57 lymphadenopathy
    58 male homosexuals
    59 monoclonal antibodies
    60 neoplasms
    61 opportunistic infections
    62 opportunistic neoplasms
    63 patients
    64 prevalence
    65 productive infection
    66 pseudotypes
    67 receptor-bearing cells
    68 receptors
    69 retroviral envelope antigen
    70 retroviruses
    71 specific components
    72 stomatitis virus
    73 subset
    74 surface CD4
    75 susceptibility
    76 susceptibility of cells
    77 syncytia
    78 syndrome
    79 vesicular stomatitis virus
    80 virus
    81 virus-producing cells
    82 schema:name The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
    83 schema:pagination 763-767
    84 schema:productId N2cdf5ea06d4d42459d9af625371639d5
    85 N4d22bd855c52484cadb81d8c2e4b0f94
    86 N758079f6ae8d477fb24c05379abbd10f
    87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021684259
    88 https://doi.org/10.1038/312763a0
    89 schema:sdDatePublished 2022-11-24T20:45
    90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    91 schema:sdPublisher N0e81d87786984b80bdb92006ada99f9b
    92 schema:url https://doi.org/10.1038/312763a0
    93 sgo:license sg:explorer/license/
    94 sgo:sdDataset articles
    95 rdf:type schema:ScholarlyArticle
    96 N0e81d87786984b80bdb92006ada99f9b schema:name Springer Nature - SN SciGraph project
    97 rdf:type schema:Organization
    98 N2a985761354d4464a03c450a13c5d0f0 rdf:first sg:person.01040665311.03
    99 rdf:rest N5777bb9168274912bf0649527abd49b7
    100 N2cdf5ea06d4d42459d9af625371639d5 schema:name doi
    101 schema:value 10.1038/312763a0
    102 rdf:type schema:PropertyValue
    103 N44f248c6d5494f88882165d78a3da128 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Acquired Immunodeficiency Syndrome
    105 rdf:type schema:DefinedTerm
    106 N4850ca447dec43af91c81d7cf87072e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Deltaretrovirus
    108 rdf:type schema:DefinedTerm
    109 N4d22bd855c52484cadb81d8c2e4b0f94 schema:name pubmed_id
    110 schema:value 6096719
    111 rdf:type schema:PropertyValue
    112 N5777bb9168274912bf0649527abd49b7 rdf:first sg:person.01060575403.86
    113 rdf:rest N5d5d96a6b7914da0bd967f6f4c2acb2f
    114 N5d5d96a6b7914da0bd967f6f4c2acb2f rdf:first sg:person.0636250107.14
    115 rdf:rest N880ad23d82384a4cb781ec9eaf41ad5e
    116 N758079f6ae8d477fb24c05379abbd10f schema:name dimensions_id
    117 schema:value pub.1021684259
    118 rdf:type schema:PropertyValue
    119 N7b10a4d9ae1543748439e6edc54ddef6 rdf:first sg:person.011763114607.07
    120 rdf:rest rdf:nil
    121 N8449f7608c694c5cb7ce3f697e6efb91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name T-Lymphocytes
    123 rdf:type schema:DefinedTerm
    124 N880ad23d82384a4cb781ec9eaf41ad5e rdf:first sg:person.0754431446.33
    125 rdf:rest Nd28f842642f44a21a0b2ff56d89bde03
    126 N881ceeb37c86451cbfb61540a9580a35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Antibodies, Monoclonal
    128 rdf:type schema:DefinedTerm
    129 N8fec1c6395494597b8f58d6f4bf412e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Vesicular stomatitis Indiana virus
    131 rdf:type schema:DefinedTerm
    132 N9382a04d78be4ef986ccdcd644da45ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Antigens, Surface
    134 rdf:type schema:DefinedTerm
    135 N9e452347fbe54d9489c5d039140779bc schema:issueNumber 5996
    136 rdf:type schema:PublicationIssue
    137 Nd28f842642f44a21a0b2ff56d89bde03 rdf:first sg:person.013377471142.72
    138 rdf:rest N7b10a4d9ae1543748439e6edc54ddef6
    139 Ne04dfa8663e842c39c8dd523671861bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Humans
    141 rdf:type schema:DefinedTerm
    142 Nf19e74a8074f4bc7b22ea6f4e49519e7 schema:volumeNumber 312
    143 rdf:type schema:PublicationVolume
    144 Nf811a0cdcdbc40518c969b4a14baceec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Receptors, Virus
    146 rdf:type schema:DefinedTerm
    147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    148 schema:name Medical and Health Sciences
    149 rdf:type schema:DefinedTerm
    150 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    151 schema:name Immunology
    152 rdf:type schema:DefinedTerm
    153 sg:journal.1018957 schema:issn 0028-0836
    154 1476-4687
    155 schema:name Nature
    156 schema:publisher Springer Nature
    157 rdf:type schema:Periodical
    158 sg:person.01040665311.03 schema:affiliation grid-institutes:grid.18886.3f
    159 schema:familyName Dalgleish
    160 schema:givenName Angus G.
    161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040665311.03
    162 rdf:type schema:Person
    163 sg:person.01060575403.86 schema:affiliation grid-institutes:grid.439749.4
    164 schema:familyName Beverley
    165 schema:givenName Peter C. L.
    166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575403.86
    167 rdf:type schema:Person
    168 sg:person.011763114607.07 schema:affiliation grid-institutes:grid.18886.3f
    169 schema:familyName Weiss
    170 schema:givenName Robin A.
    171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011763114607.07
    172 rdf:type schema:Person
    173 sg:person.013377471142.72 schema:affiliation grid-institutes:grid.18886.3f
    174 schema:familyName Greaves
    175 schema:givenName Melvyn F.
    176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013377471142.72
    177 rdf:type schema:Person
    178 sg:person.0636250107.14 schema:affiliation grid-institutes:grid.18886.3f
    179 schema:familyName Clapham
    180 schema:givenName Paul R.
    181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636250107.14
    182 rdf:type schema:Person
    183 sg:person.0754431446.33 schema:affiliation grid-institutes:grid.439749.4
    184 schema:familyName Crawford
    185 schema:givenName Dorothy H.
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754431446.33
    187 rdf:type schema:Person
    188 sg:pub.10.1038/312767a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028751316
    189 https://doi.org/10.1038/312767a0
    190 rdf:type schema:CreativeWork
    191 grid-institutes:grid.18886.3f schema:alternateName Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK
    192 schema:name Cell and Molecular Biology Section and LRF Centre, Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, SW3 6JB, London, UK
    193 rdf:type schema:Organization
    194 grid-institutes:grid.439749.4 schema:alternateName ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK
    195 schema:name ICRF Human Tumour Immunology Group and Department of Haematology, University College Hospital Medical School, WC1E 6HX, London, UK
    196 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...